FDA anticipates disruptions, shortages as China outbreak plays out

17th February 2020 Uncategorised 0

The FDA is bracing for drug and medical supply shortages in the U.S. as the COVID-19 outbreak from China continues to spread globally. The agency has contacted hundreds of drug and device makers and so far the links of the supply chain have held but will take whatever measures it can if disruptions appear. 

More: FDA anticipates disruptions, shortages as China outbreak plays out
Source: fierce